• Facebook
  • Twitter
Phone: (843) 449-1010 | 823 82nd Parkway, Suite B, Myrtle Beach, SC 29572
Carolina Urologic Research Center - Myrtle Beach, SC
  • Home
  • About Us
  • Staff
    • Clinical Investigators
    • Clinical Staff
    • Associated Providers
  • Current Trials
    • Bladder Cancer
    • Prostate Cancer
    • Other
    • Patient Trials Form
  • Patient Info
    • Patient Info
    • Helpful Links
    • Q&A About Clinical Trials
  • Testimonials
  • In The News
    • In The News
  • Contact
  • Search
  • Menu Menu
Blog - Latest News
You are here: Home1 / Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility. By Dr. Neal Shore2 / 3.27-AbirateroneAcetate

3.27-AbirateroneAcetate

March 27, 2017/by CURC

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
/wp-content/uploads/logo-1.png 0 0 CURC /wp-content/uploads/logo-1.png CURC2017-03-27 08:36:542017-03-27 08:36:543.27-AbirateroneAcetate

Current Happenings

  • Dr. Shore Presents Practice-Changing Data In Prostate Cancer / EMBARK points to potential new standard of care for high-risk BCR.
  • AUA Chicago April 28 – May 1, 2023- Here We Come
  • Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303
  • Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
  • Efficacy of Enzalutamide Plus Androgen Deprivation Therapy In Metastatic Hormone-Sensitive Prostate Cancer By Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
  • Comparison of Germline Mutations In African American And Caucasian Men With Metastatic Prostate Cancer
  • Niraparib With Androgen Receptor-Axis-Targeted Therapy In Patients With Metastatic Castration-Resistant Prostate Cancer: Safety And Pharmacokinetic Results From A Phase 1b Study (BEDIVERE)
  • Combined Advanced Prostate Cancer Treatments- Are They Additive?

Archives

Contact

Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572

Phone: (843) 839-1679
Fax: (843) 286-0119

Email:
info@curcmb.com

Directions

Recent Happenings

  • Dr. Shore Presents Practice-Changing Data In Prostate Cancer / EMBARK points to potential new standard of care for high-risk BCR.
  • AUA Chicago April 28 – May 1, 2023- Here We Come
  • Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303
  • Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia

Our Affiliates

©2023 Carolina Urologic Research Center, LLC | All Rights Reserved | Site Design by Studio303, Inc.
  • Facebook
  • Twitter
Scroll to top